ArticlePublic health weekly report2026
HIV/AIDS Notification Status and Trends in the Republic of Korea, 2021-2025.
Article in Public health weekly report, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Objectives: Human immunodeficiency virus (HIV) infection remains a critical public health priority requiring sustained prevention, early diagnosis, and timely treatment. This surveillance report examined 5-year trends in newly notified HIV cases in the Republic of Korea (ROK) from 2021 to 2025. Methods: Annual notification counts and demographic characteristics for 2021-2025 were examined using the "2025 Annual Report on the Notified HIV/AIDS" in the ROK, which compiles cases reported to the Korea Disease Control and Prevention Agency. Transmission routes and testing motivations among Korean nationals were also summarized. Results: A total of 973, 1,065, 1,005, 975, and 927 newly notified HIV cases were reported in 2021, 2022, 2023, 2024, and 2025, respectively, with the number declining continuously after 2022. The proportion of foreign nationals increased from 20.9% (203/973) in 2021 to 28.9% (268/927) in 2025. Among the 4,945 cases notified during the 5 years, 4,468 (90.4%) were male, and 3,259 (65.9%) were aged 20-39 years. Among respondents to the transmission-route item, male-to-male sexual contact accounted for 1,647 cases (60.7%), whereas heterosexual contact accounted for 1,053 cases (38.8%). Voluntary testing was the most common testing motivation, accounting for 1,052 cases (29.5%). Conclusions: Although the total number of newly notified HIV cases declined after 2022, the proportion of foreign nationals increased, while males and persons aged 20-39 years remained predominant among newly notified cases. Prevention efforts should strengthen promotion of pre-exposure prophylaxis, access to HIV testing, and timely linkage to treatment among young adults, males, and populations at increased risk. Tailored multilingual prevention, testing, counseling, and treatment-linkage services should also be expanded for foreign nationals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.